Back
Aspen Technology 10K Form
Buy
52
AZPN
Aspen Technology
Last Price:
$264.33
Seasonality Move:
10.43%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2022-04-27 | 10Q | AZPN/Aspen Technology Quarterly |
2022-01-26 | 10Q | AZPN/Aspen Technology Quarterly |
2021-10-27 | 10Q | AZPN/Aspen Technology Quarterly |
2021-08-18 | 10K | AZPN/Aspen Technology Annual |
2021-04-28 | 10Q | AZPN/Aspen Technology Quarterly |
2021-01-27 | 10Q | AZPN/Aspen Technology Quarterly |
Receive AZPN News And Ratings
See the #1 stock for the next 7 days that we like better than AZPN
AZPN Financial Statistics
Sales & Book Value
Annual Sales: | $1.1B |
---|---|
Cash Flow: | $36.4M |
Price / Cash Flow: | 52.45 |
Annual Sales: | $201.83 |
Price / Book: | 1.31 |
Profitability
EPS (TTM): | 0.08000 |
---|---|
Net Income (TTM): | $6.1M |
Gross Margin: | $744.9M |
Return on Equity: | 0.05% |
Return on Assets: | 0.04% |
Aspen Technology Earnings Forecast
Key Aspen Technology Financial Ratios
-
The Gross Profit Margin over the past 29 years for AZPN is 66.07%.
-
The Selling, General & Administrative Expenses for AZPN have been equal to 55.73% of Gross Profit Margin.
-
The Research & Development expenses have been 18.28% of Revenue.
-
The Interest Expense is 2.27% of Operating Income.
-
The Net Earning history of AZPN is -0.87% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 15 years.
Aspen Technology Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Software |
Sector: | Information Technology |
Current Symbol: | AZPN |
CUSIP: | 045327 |
Website: | aspentech.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 3.33 |
Quick Ratio: | 3.19 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 32.41 |
AZPN Technical Analysis vs Fundamental Analysis
Buy
52
Aspen Technology (AZPN)
is a Buy
Is Aspen Technology a Buy or a Sell?
-
Aspen Technology stock is rated a BuyThe current Aspen Technology [AZPN] share price is $264.33. The Score for AZPN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.